Clinical Trial Update: Phase I Dose Escalation of BAY1143572 in Subjects With Acute Leukemia [Phase 1]

View source ↗

Summary

Phase I dose-escalation trial of BAY1143572 in subjects with acute leukemia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leukemia

Drugs mentioned

• BAY1143572

Snippet

Sponsor: Bayer | Conditions: Leukemia | Phase 1 | Status: COMPLETED